Penumbra (PEN) Stock Forecast & Price Target

Compare

475 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PEN Analyst Ratings

Hold

3 Buy

13 Hold

0 Sell

Based on 16 analysts giving stock ratings to

Penumbra

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PEN Stock 12 Month Forecast

Average Price Target

$361.83

▲(3.15% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for Penumbra in the last 3 months. The average price target is $361.83 with a high forecast of $374.00 and a low forecast of $266.00. The average price target represents a 3.15% change from the last price of $350.78.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"226":"$226","375":"$375","263.25":"$263.3","300.5":"$300.5","337.75":"$337.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":374,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$374.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":361.8333333333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$361.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":266,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$266.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[226,263.25,300.5,337.75,375],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,310.91,315.76307692307694,320.61615384615385,325.46923076923076,330.32230769230773,335.17538461538464,340.02846153846156,344.88153846153847,349.7346153846154,354.5876923076923,359.4407692307692,364.2938461538462,369.1469230769231,{"y":374,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,310.91,314.82717948717954,318.744358974359,322.6615384615385,326.57871794871795,330.49589743589746,334.4130769230769,338.3302564102564,342.2474358974359,346.1646153846154,350.08179487179484,353.99897435897435,357.91615384615386,{"y":361.8333333333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,310.91,307.4553846153846,304.00076923076927,300.54615384615386,297.0915384615385,293.6369230769231,290.1823076923077,286.72769230769234,283.2730769230769,279.8184615384615,276.36384615384617,272.90923076923076,269.4546153846154,{"y":266,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":237.48,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":266.97,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":285.44,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.13,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.82,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":256.16,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":250.68,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.01,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":269.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":249.63,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":227.37,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.66,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":310.91,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$374.00

Average Price Target$361.83

Lowest Price Target$266.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Shagun Singh Chadha

RBC Capital

$355→$374

Hold

6.62%

Upside

Downgraded

01/20/26

Penumbra downgraded to Sector Perform from Outperform at RBC CapitalPenumbra downgraded to Sector Perform from Outperform at RBC Capital

Priya Sachdeva

UBS

$335→$374

Hold

6.62%

Upside

Downgraded

01/20/26

UBS downgrades Penumbra (PEN) to a Hold

William Plovanic

Canaccord Genuity

$359→$374

Hold

6.62%

Upside

Downgraded

01/19/26

Penumbra: Rating Cut to Hold as Boston Scientific Takeout Caps Upside at $374 Deal Price

Brandon Vazquez

William Blair

Hold

―

Downgraded

01/17/26

Penumbra downgraded to Market Perform from Outperform at William BlairPenumbra downgraded to Market Perform from Outperform at William Blair

Richard Newitter

Truist Financial

$370→$374

Hold

6.62%

Upside

Downgraded

01/16/26

Analysts Offer Insights on Healthcare Companies: Boston Scientific (NYSE: BSX), Atea Pharmaceuticals (NASDAQ: AVIR) and Penumbra (NYSE: PEN)

Joanne Wuensch

Citi

$350→$374

Hold

6.62%

Upside

Downgraded

01/16/26

Penumbra downgraded to Neutral from Buy at CitiPenumbra downgraded to Neutral from Buy at Citi

Larry Biegelsen

Wells Fargo

$374

Hold

6.62%

Upside

Downgraded

01/16/26

Penumbra downgraded to Equal Weight from Overweight at Wells FargoPenumbra downgraded to Equal Weight from Overweight at Wells Fargo

Michael Matson

Needham

Hold

―

Downgraded

01/16/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (NASDAQ: ARCT) and Penumbra (NYSE: PEN)

Ryan Zimmerman

BTIG

Hold

―

Downgraded

01/16/26

Analysts Offer Insights on Healthcare Companies: Elevance Health (NYSE: ELV) and Penumbra (NYSE: PEN)

Mike Kratky

Leerink Partners

$374

Hold

6.62%

Upside

Downgraded

01/15/26

Penumbra downgraded to Market Perform from Outperform at LeerinkPenumbra downgraded to Market Perform from Outperform at Leerink

Travis Steed

Bank of America Securities

Buy

―

Reiterated

01/15/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

David Rescott

Robert W. Baird

$345→$374

Hold

6.62%

Upside

Downgraded

01/15/26

Robert W. Baird downgrades Penumbra (PEN) to a Hold

Matthew O'Brien

Piper Sandler

$330→$374

Hold

6.62%

Upside

Downgraded

01/15/26

Penumbra downgraded to Neutral from Overweight at Piper SandlerPenumbra downgraded to Neutral from Overweight at Piper Sandler

Vijay Kumar

Evercore ISI

$286→$340

Buy

-3.07%

Downside

Reiterated

01/05/26

Penumbra price target raised to $340 from $286 at Evercore ISIPenumbra price target raised to $340 from $286 at Evercore ISI

Robbie Marcus

J.P. Morgan

$275→$370

Buy

5.48%

Upside

Upgraded

12/18/25

Penumbra: Accelerating Growth, Margin Upside, and 2026+ Catalysts Support Overweight (Buy) Rating

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Shagun Singh Chadha

RBC Capital

$355→$374

Hold

6.62%

Upside

Downgraded

01/20/26

Penumbra downgraded to Sector Perform from Outperform at RBC CapitalPenumbra downgraded to Sector Perform from Outperform at RBC Capital

Priya Sachdeva

UBS

$335→$374

Hold

6.62%

Upside

Downgraded

01/20/26

UBS downgrades Penumbra (PEN) to a Hold

William Plovanic

Canaccord Genuity

$359→$374

Hold

6.62%

Upside

Downgraded

01/19/26

Penumbra: Rating Cut to Hold as Boston Scientific Takeout Caps Upside at $374 Deal Price

Brandon Vazquez

William Blair

Hold

―

Downgraded

01/17/26

Penumbra downgraded to Market Perform from Outperform at William BlairPenumbra downgraded to Market Perform from Outperform at William Blair

Richard Newitter

Truist Financial

$370→$374

Hold

6.62%

Upside

Downgraded

01/16/26

Analysts Offer Insights on Healthcare Companies: Boston Scientific (NYSE: BSX), Atea Pharmaceuticals (NASDAQ: AVIR) and Penumbra (NYSE: PEN)

Joanne Wuensch

Citi

$350→$374

Hold

6.62%

Upside

Downgraded

01/16/26

Penumbra downgraded to Neutral from Buy at CitiPenumbra downgraded to Neutral from Buy at Citi

Larry Biegelsen

Wells Fargo

$374

Hold

6.62%

Upside

Downgraded

01/16/26

Penumbra downgraded to Equal Weight from Overweight at Wells FargoPenumbra downgraded to Equal Weight from Overweight at Wells Fargo

Michael Matson

Needham

Hold

―

Downgraded

01/16/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (NASDAQ: ARCT) and Penumbra (NYSE: PEN)

Ryan Zimmerman

BTIG

Hold

―

Downgraded

01/16/26

Analysts Offer Insights on Healthcare Companies: Elevance Health (NYSE: ELV) and Penumbra (NYSE: PEN)

Mike Kratky

Leerink Partners

$374

Hold

6.62%

Upside

Downgraded

01/15/26

Penumbra downgraded to Market Perform from Outperform at LeerinkPenumbra downgraded to Market Perform from Outperform at Leerink

Travis Steed

Bank of America Securities

Buy

―

Reiterated

01/15/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

David Rescott

Robert W. Baird

$345→$374

Hold

6.62%

Upside

Downgraded

01/15/26

Robert W. Baird downgrades Penumbra (PEN) to a Hold

Matthew O'Brien

Piper Sandler

$330→$374

Hold

6.62%

Upside

Downgraded

01/15/26

Penumbra downgraded to Neutral from Overweight at Piper SandlerPenumbra downgraded to Neutral from Overweight at Piper Sandler

Vijay Kumar

Evercore ISI

$286→$340

Buy

-3.07%

Downside

Reiterated

01/05/26

Penumbra price target raised to $340 from $286 at Evercore ISIPenumbra price target raised to $340 from $286 at Evercore ISI

Robbie Marcus

J.P. Morgan

$275→$370

Buy

5.48%

Upside

Upgraded

12/18/25

Penumbra: Accelerating Growth, Margin Upside, and 2026+ Catalysts Support Overweight (Buy) Rating

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Penumbra

3 Months

xxx

Success Rate

0/0 ratings generated profit

Average Return

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in - of your transactions generating a profit, with an average return of - per trade.

1 Year

Travis SteedBank of America Securities

Success Rate

8/8 ratings generated profit

Average Return

+18.66%

reiterated a buy rating 6 days ago

Copying Travis Steed's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +18.66% per trade.

2 Years

xxx

Success Rate

0/0 ratings generated profit

Average Return

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in - of your transactions generating a profit, with an average return of - per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PEN Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, PEN has received 25 Buy Ratings, 15 Hold Ratings, and 0 Sell Ratings. PEN average Analyst price target in the past 3 months is 361.83.

Each month's total comprises the sum of three months' worth of ratings.

PEN Financial Forecast

PEN Earnings Forecast

Next quarter’s earnings estimate for PEN is $1.09 with a range of $0.99 to $1.24. The previous quarter’s EPS was $0.97. PEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year PEN has Performed in-line its overall industry.

PEN Sales Forecast

Next quarter’s sales forecast for PEN is $361.80M with a range of $358.96M to $366.00M. The previous quarter’s sales results were $354.69M. PEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year PEN has Performed in-line its overall industry.

PEN Stock Forecast FAQ

What is PEN’s average 12-month price target, according to analysts?

Based on analyst ratings, Penumbra’s 12-month average price target is 361.83.

What is PEN’s upside potential, based on the analysts’ average price target?

Penumbra has 3.15% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is PEN a Buy, Sell or Hold?

Penumbra has a consensus rating of Hold which is based on 3 buy ratings, 13 hold ratings and 0 sell ratings.

What is Penumbra’s price target?

The average price target for Penumbra is 361.83. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $374.00 ,the lowest forecast is $266.00. The average price target represents 3.15% Increase from the current price of $350.78.

What do analysts say about Penumbra?

Penumbra’s analyst rating consensus is a Hold. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of PEN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Penumbra (PEN) Stock Forecast & Price Target

PEN Analyst Ratings

PEN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Penumbra

PEN Analyst Recommendation Trends

PEN Financial Forecast

PEN Earnings Forecast

PEN Sales Forecast

PEN Stock Forecast FAQ

Detailed List of Analyst Forecasts